Page last updated: 2024-09-03

pd 81723 and threonine

pd 81723 has been researched along with threonine in 1 studies

Compound Research Comparison

Studies (pd 81723)	Trials (pd 81723)	Recent Studies (post-2010) (pd 81723)	Studies (threonine)	Trials (threonine)	Recent Studies (post-2010) (threonine)
55	0	12	10,383	98	2,176

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Groote, M; IJzerman, AP; Kourounakis, A; Visser, C	1

Other Studies

1 other study(ies) available for pd 81723 and threonine

Article	Year
Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor. Biochemical pharmacology, 2001, Jan-15, Volume: 61, Issue:2 Topics: Alanine; Allosteric Regulation; Binding, Competitive; Cells, Cultured; Cyclic AMP; Humans; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Thiophenes; Threonine	2001

Article

Year

Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.

Biochemical pharmacology, 2001, Jan-15, Volume: 61, Issue:2

Topics: Alanine; Allosteric Regulation; Binding, Competitive; Cells, Cultured; Cyclic AMP; Humans; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Thiophenes; Threonine

2001